ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Alfasigma acquires the European license for bentracimab from PhaseBio prnasia
June 22, 2021Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc., for the commercialization of bentracimab in 49 countries across Europe and other key markets. -
PhaseBio and BioVectra Enter into Supply Agreement contractpharma
March 12, 2021?PhaseBio Pharmaceuticals, a clinical-stage biotech focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra, a global contract development and manufacturing organization (CDMO), have entered a ...
Pharma Sources Insight January 2025
